$94.2 Million is the total value of Partner Investment Management, L.P.'s 81 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | AMGEN INCput | $2,506,000 | – | 13,600 | +100.0% | 2.66% | – | |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $2,193,000 | – | 25,610 | +100.0% | 2.33% | – |
| DIS | New | DISNEY WALT CO | $1,736,000 | – | 12,429 | +100.0% | 1.84% | – |
| PGR | New | PROGRESSIVE CORP OHIO | $1,648,000 | – | 20,617 | +100.0% | 1.75% | – |
| GILD | New | GILEAD SCIENCES INC | $1,426,000 | – | 21,102 | +100.0% | 1.51% | – |
| TWTR | New | TWITTER INC | $1,294,000 | – | 37,074 | +100.0% | 1.37% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $1,023,000 | – | 6,730 | +100.0% | 1.09% | – |
| New | PFIZER INCcall | $983,000 | – | 22,700 | +100.0% | 1.04% | – | |
| DXCM | New | DEXCOM INC | $872,000 | – | 5,818 | +100.0% | 0.93% | – |
| New | ISHARES TRput | $575,000 | – | 13,400 | +100.0% | 0.61% | – | |
| New | AMGEN INCcall | $553,000 | – | 3,000 | +100.0% | 0.59% | – | |
| CTLT | New | CATALENT INC | $431,000 | – | 7,952 | +100.0% | 0.46% | – |
| New | SPDR SERIES TRUSTcall | $395,000 | – | 4,500 | +100.0% | 0.42% | – | |
| THC | New | TENET HEALTHCARE CORP | $394,000 | – | 19,048 | +100.0% | 0.42% | – |
| ICLR | New | ICON PLC | $259,000 | – | 1,679 | +100.0% | 0.28% | – |
| AVTR | New | AVANTOR INC | $228,000 | – | 11,964 | +100.0% | 0.24% | – |
| INGN | New | INOGEN INC | $124,000 | – | 1,852 | +100.0% | 0.13% | – |
| CRWD | New | CROWDSTRIKE HLDGS INCcl a | $118,000 | – | 1,730 | +100.0% | 0.12% | – |
| KRTX | New | KARUNA THERAPEUTICS INC | $116,000 | – | 7,219 | +100.0% | 0.12% | – |
| TW | New | TRADEWEB MKTS INCcl a | $93,000 | – | 2,132 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 25 | Q4 2019 | 1.9% |
| HCA HOLDINGS INC | 23 | Q4 2019 | 5.4% |
| HUMANA INC | 22 | Q4 2019 | 3.5% |
| EDWARDS LIFESCIENCES CORP | 21 | Q4 2019 | 3.7% |
| CLOVIS ONCOLOGY INC | 20 | Q3 2018 | 6.6% |
| UNITEDHEALTH GROUP INC | 19 | Q4 2019 | 5.0% |
| MEDICINES CO | 19 | Q3 2018 | 3.0% |
| AERIE PHARMACEUTICALS INC | 18 | Q4 2019 | 3.1% |
| SALESFORCE COM INC | 17 | Q3 2019 | 2.7% |
| NETFLIX INC | 17 | Q2 2019 | 5.6% |
View Partner Investment Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2020-11-16 |
| 13F-NT | 2020-08-14 |
| 13F-NT | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-14 |
View Partner Investment Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.